Klin Farmakol Farm. 2010;24(4):190-196

Reliability of computer programs providing support for electronic prescribing of drug interactions

Michal Prokeš, Josef Suchopár
INFOPHARM a. s., Praha

Computer programs offering electronic prescription support (EPP) are in developed countries widely dispersed, but they are not exploited

in an optimal way routinely. In this paper elaborated on the basis of foreign studies we describe the rate of the change of physicians

´s prescribing habbits evoked by EPP programs on the field of potential drug interactions (PLI) and also is shown how physicians

percieve such programs. Physicians consider these programs being helpfull but are worried about credibility of information provided

by these programs and consider some warnings issued by these programs as irrelevant and bothering. In the second part ot this paper

the methodology of sensitivity and specifity analysis of programs offering EPP on the field of PLI are described and outcomes of studies

measuring the dependability of these programs are presented. Authors emphasize the importance of appraisals of these programs for

physicians in clinical practice and advice against some pitfalls in these area.

Keywords: electronic prescription support, potential drug interactions, rational pharmacotherapy support

Published: December 31, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Prokeš M, Suchopár J. Reliability of computer programs providing support for electronic prescribing of drug interactions. Klin Farmakol Farm. 2010;24(4):190-196.
Download citation

References

  1. Kaushal R, Kaveh G, Shojania KG, et al. Effects of computerized physician order entry and clinical decision support systems on madication safety. Arch Intern med 2003; 163: 1409-1416. Go to original source... Go to PubMed...
  2. Walton R, Dovey S, Harvey E, et al. Computer support for determining drug dose: systematic review and meta-analysis. Br Med J 1999; 318: 984-990. Go to original source... Go to PubMed...
  3. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert systém to prevent injury from adverse drug events: Developoment and evaluation in a community teaching hospital. JAMA 1998; 280: 1317-1320. Go to original source... Go to PubMed...
  4. Hunt D, Haynes RB, Hanna SE, et al. Effects of computerbased clinical decision support systems on physician performance and patient outcomes. JAMA 1998; 280: 1339-1346. Go to original source... Go to PubMed...
  5. Rind DM, Safran C, Phillips RS, et al. Effect of computerbased alerts on the treatment and outcomes of hospitalised patients. Arch Intern Med 1994; 154: 1511-1517. Go to original source...
  6. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 2080: 1311-1316. Go to original source... Go to PubMed...
  7. Halkin H, Kathir I, Kurman I, et al. Preventing drug interactions by online prescription screening in community pharmacies and medical practices. Clin Pharmacol Ther 2001; 69: 260-265. Go to original source... Go to PubMed...
  8. Tamblyn R, Huang A, Perrault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ 2003; 169(6): 549-556.
  9. Bates DW, Sohen M, Leape LL, et al. reducing the frequency of errors in medicine using information technology. J Am Med Inform Assoc 2001; 8: 299-308. Go to original source... Go to PubMed...
  10. Bates DW, Kuperman GJ, Wand S, et al. Ten commandements for effective clinical decision support: Making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 2003; 10: 523-530. Go to original source... Go to PubMed...
  11. Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC CLinical Pharmacology 2007; 7: 9-20. Go to original source... Go to PubMed...
  12. Waller P, Shaw M, Ho D, et al. Hospital admissions for drug induced disorders in England: a study using the hospital episodes statistics database. Br J Clin Pharmacol 2005; 59: 213-215. Go to original source... Go to PubMed...
  13. Pirmohamed M, James S, Meakin S, et al. Averse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 326: 15-19, http://www.bmj.com/cgi/reprint/329/7456/15. Go to original source... Go to PubMed...
  14. Classen DC, Pestotnik L, Evans RS, et al. Adverse drug events in hospitalized patients. Escess length of stay, extra costs and attributiable mortality. JAMA 1997; 227: 301-306. Go to original source...
  15. Davies EC, Green CF, Taylor S, et al. Averse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635959/pdf/pone.0004439.pdf.
  16. Yu DT, Peterson JF, Seger DL, et al. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions. Pharmacoepidemiol Drug Saf 2005; 14: 755-767. Go to original source... Go to PubMed...
  17. Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf 2006; 29: 79-90. Go to original source... Go to PubMed...
  18. Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 2003; 58: 773-778. Go to original source... Go to PubMed...
  19. Kohler GI, Bode-Boger SM, Busse R, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000; 38: 504-513. Go to original source... Go to PubMed...
  20. Laine K, Forsstrom J, Gronroos P, et al. Frequency and clinical outcome of potentially harmful drug metabolic interactions in patients hospitalised on internal and pulmonary medicine wards: focus on warfarin and cisapride. Ther Drug Monit 2000; 22: 503-509. Go to original source... Go to PubMed...
  21. Trikkonen T, Laine K. Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients. Clin Pharmacol Ther 2005; 78: 93.
  22. Tabmlyn R, Huang A, Kawasumi Y, et al. The Development and Evaluation of an Integrated Electronic Prescribing and Drug Management System for Primary Care. Am J Med Inform Assoc 2006; 13: 148-159. Go to original source... Go to PubMed...
  23. Weingart SN, Toth M, Sands DZ, et al. Physicians´s Decision to Override Computerized Drug Alerts in Primary Care. Arch Intern Med 2003; 163: 2625-2631. Go to original source... Go to PubMed...
  24. Shah NR, Seger AC, Seger DL, et al. Improving Acceptance of Computerized Prescribing Alerts in Ambulatory Care. J Am Med Inform Assoc 2006; 13: 5-11. Go to original source... Go to PubMed...
  25. Tamblyn R, Huang A, Taylor L, et al. A Randomized Trial of the Effectiveness of On-demand versus Computer-triggered Drug Decision Support in Primary Care. J Am Med Inform Assoc 2008; 15: 430-438. Go to original source... Go to PubMed...
  26. Ahearn DM, Kerr SJ. Genaral practitioner´s perception of the pharmaceutical decision-support tools in their prescribing software. MJA 2003; 179: 34-37. Go to original source... Go to PubMed...
  27. Lapane KL, Waring ME, Schneider KL, et al. A Mixed Method Study of the Merits of E-Prescribing Drug Alerts in Primary Care. J Gen Intern Med 2008; 23: 442-446. Go to original source... Go to PubMed...
  28. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am med Inform Assoc 2006; 13: 138-147. Go to original source... Go to PubMed...
  29. van der Sijs H, van Gelder T, Vulto A, et al. Understanding handling of drug safety alerts: a simulation study. Int J Med Inform 2010; Feb 18 (Epub ahead of print). Go to original source... Go to PubMed...
  30. van der Sijs H, Kowlesar R, Klootwijk PJ, et al. Clinically relevant QTc prolonagtion due to overridden drug-drug alerts: a retrospective cohort study. Br J Clin Pharmacol 2009; 67: 347-354. Go to original source... Go to PubMed...
  31. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am med Inform Assoc 2006; 13: 138-147. Go to original source... Go to PubMed...
  32. Fernando B, Savelyich BS, Avery AJ, et al. Prescribing safety features of general practice computer systems: evaluating using simulated test cases. BMJ 2004; 328: 1171-1172. Go to original source... Go to PubMed...
  33. Abarca J, Colón LR, Wang VS, et al. Evaluating ot the Performance of Drug-Drug Interaction Screening Software in Community and Hospital Pharmacies. Journal of Managed Care Pharmacy 2006; 12: 383-389. Go to original source... Go to PubMed...
  34. Sweidan M, Reeve JF, Brien JE, et al. Quality of drug interaction alerts in prescribing and dispensing software. Med J Aust 2009; 190: 251-254. Go to original source... Go to PubMed...
  35. Stockley Editorial Team. Stockley´s interaction alerts (electronic version). London: Pharmaceutical Press 2006. http://www.medicinescomplete.com (accessed Spet-Nov 2006).
  36. MIMS Australia. eMIMS version 5.00.0270. Sydney: CMPMedica Australia, 2006.
  37. Rossi S, editor. Australian medicines handbook (electronic version). Adelaide: Australian Medicines Handbook, 2007. http://www.amh.net.au (accessed Spet-Nov 2006).
  38. Facts & Comparisons 3.0. Drug interaction facts (electronic version). St Louis, Mo: Facts&Comparisons, 2006 http://www.factsandcomparisons.com (accessed Sep-Nov 2006).
  39. Moore LL, Minne K, Moore KB. DRUG-REAX System. Greenwood Village, CO: Micromedex; 2001.
  40. Kompendium lékových interakcí INFOPHARM, Praha (elektronická verze platná od 1. 7. 2009).
  41. Baxter K, Davis M, Driver S, et al. Stockley´s Drug Intweractions. Eight edition 2008, Pharmaceutical Press, Great Britain; ISBN 978 0 85369 754 1, též elektronická verze.
  42. Hansten PD, Horn JR. Drug Interactions, analysis and management. Wolters Kluwer Health, Inc. 2004. St. Louis, Missouri, USA. ISBN: 1-57439-095-3.
  43. Bachmann KA, Lewis JD, Fuller AMA, Bonfiglio MF. Drug Interactions Handbook. Lexi/Comp, Inc. Hudson, Ohio, USA, 2003. ISBN: 1-59195-015-5.
  44. British National Formulary March 2008. ISBN: 978-085369 776-3.
  45. Ziegelmeier M, Hein T. Lékové interakce. Farmakoterapie v klinické praxi. Triton 2006, Praha. ISBN: 80-7254-755-0.
  46. Magulová L, Božeková L, Kriška M, a kolektív. Interakcie liečiv v klinickej praxi 2. vydanie. Slovak Academic Press, Bratislava 2004. ISBN 80-89104-53-3.
  47. Taylor LK, Kawasumi Y, Bartlett G, et al. Inappropriate prescribing practices: The challenge and Opportunity for Patient Safety. Healthcare Quarterly 2005; 8: 81-85. Go to original source... Go to PubMed...
  48. Judge J, Field TS, DeFlorio M, et al. Prescribers´response to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc 2006; 13: 385-390. Go to original source... Go to PubMed...
  49. Ko Y, Abarca J, Malone DC, et al. Practioners´views on computerized drug-drug interaction alerts in the VA systém. J Am Med Inform Assoc 2007; 14: 56-64. Go to original source... Go to PubMed...
  50. Lin CP, Payne TH, Nichol WP, et al. Evaluating clinical decision support systems: Monitoring CPOE order check override rates in the departments of Veterans affairs´computerized patient record systém. J Am Med Inform Assoc 2008; 15: 620-626. Go to original source... Go to PubMed...
  51. Mille F, Schwartz C, Brion F, et al. Analysis of overridden alerts in a drug-drug interaction detection system. International Journal for Quality in Health Care 2008; 20: 400-405. Go to original source... Go to PubMed...
  52. Isaac T, Weissman JS, Davis RB, et al. Overrides of medication alerts in ambulatory care. Arch intern med 2009; 169: 305-311. Go to original source... Go to PubMed...
  53. Abarca J, Malone C, Armstrong EP, et al. Concordance of Severity Rating Provided in Four Drug Interaction Compendia. Am J Pharm Assoc 2004; 44: 136-141. Go to original source... Go to PubMed...
  54. Böttiger Y, Laine K, Andersson ML, et al. SFINX - a drugdrug interaction database designed for clinical decision support systems. Eur J Clin Pharmacol 2009; 65: 627-633. Go to original source... Go to PubMed...
  55. Hansen PB, Buch J, Rasmussen OO, et al. Influence of atenolol and nifedipine on digoxin-induced inotropism in humans. Br J Clin Pharmacol 1984; 18: 817-822. Go to original source... Go to PubMed...
  56. Neely JL, Abate M, Swinker M, D´Angio R. The effect of doxycycline on serum levels of ehtinyl estradiol, norethindrone, and endogenous progresterone. Obstetr Gynecol 1991; 77: 416-420. Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.